Publications

Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy – reaching beyond germline BRCA mutations

Authors: E Swisher, I McNeish, RL Coleman, JD Brenton, SH Kaufmann, A Allen, M Rapon...

E-pub date: 1 Aug 2014

Journal name: CANCER RESEARCH

Immunohistochemistry predicts presence and type of TP53 mutation in high-grade serous carcinoma

Authors: M Koebel, A Piskorz, S Liu, JD Brenton

E-pub date: 1 Aug 2014

Journal name: CANCER RESEARCH

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

Authors: EM Swisher, IA McNeish, RL Coleman, J Brenton, SH Kaufmann, AR Allen, M Rap...

E-pub date: 1 Aug 2014

Journal name: JOURNAL OF CLINICAL ONCOLOGY

A national platform for molecular diagnostics: Results of the Cancer Research UK Stratified Medicine Programme

Authors: E Shaw, R Butler, DG de Castro, M Griffiths, A Hanby, J Hair, F Rae, J Roga...

E-pub date: 1 Aug 2014

Journal name: JOURNAL OF CLINICAL ONCOLOGY

ICON8: An international randomized trial comparing two dose dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carhoplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer

Authors: J Hook, SP Stenning, J Brenton, SB Kaye, IA McNeish, R Naik, T Perron, J Pe...

E-pub date: 1 Aug 2014

Journal name: JOURNAL OF CLINICAL ONCOLOGY

HER2 binds to the genome at specific regulatory sites of key genes in breast cancer

Authors: A Redmond, JS Carroll

E-pub date: 1 Aug 2014

Journal name: EUROPEAN JOURNAL OF CANCER

Quantitation of a spin polarization-induced nuclear Overhauser effect (SPINOE) between a hyperpolarized (13) C-labeled cell metabolite and water protons.

Authors: I Marco-Rius, SE Bohndiek, MI Kettunen, TJ Larkin, M Basharat, C Seeley, KM...

E-pub date: 1 Aug 2014

Journal name: Contrast Media Mol Imaging

Magnetic resonance imaging of tumour metabolism

Authors: KM Brindle, DE Hu, TB Rodrigues, EM Serrao, KN Timm

E-pub date: 1 Aug 2014

Journal name: EUROPEAN JOURNAL OF CANCER

Filters

Research Groups

Core Facilities

Start date

End date

Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy – reaching beyond germline BRCA mutations

Immunohistochemistry predicts presence and type of TP53 mutation in high-grade serous carcinoma

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

A national platform for molecular diagnostics: Results of the Cancer Research UK Stratified Medicine Programme

ICON8: An international randomized trial comparing two dose dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carhoplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer

HER2 binds to the genome at specific regulatory sites of key genes in breast cancer

Quantitation of a spin polarization-induced nuclear Overhauser effect (SPINOE) between a hyperpolarized (13) C-labeled cell metabolite and water protons.

Magnetic resonance imaging of tumour metabolism

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Prospective molecular identification of ovarian cancer patients benefiting from PARP inhibitor (PARPi, rucaparib) maintenance therapy – reaching beyond germline BRCA mutations

Immunohistochemistry predicts presence and type of TP53 mutation in high-grade serous carcinoma

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

A national platform for molecular diagnostics: Results of the Cancer Research UK Stratified Medicine Programme

ICON8: An international randomized trial comparing two dose dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carhoplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer

HER2 binds to the genome at specific regulatory sites of key genes in breast cancer

Quantitation of a spin polarization-induced nuclear Overhauser effect (SPINOE) between a hyperpolarized (13) C-labeled cell metabolite and water protons.

Magnetic resonance imaging of tumour metabolism